by Kristin Samuelson, Northwestern University Fig. 1. A low dose Ad5-SARS-CoV-2 spike vaccine prime elicits more SARS-CoV-2 CD8+ T cells after boosting compared to a standard dose prime. (A) Experimental approach for evaluating how the priming dose, either 106 PFU (low dose, LD) or 109 PFU (standard dose, SD) of an Ad5-SARS-CoV-2 spike vaccine affects CD8+...
